✦ LIBER ✦

Interferon A-2B treatment of chronic active Hepatitis B; A controlled, single-blind histolooical study

✍ Scribed by Kitis, G.; Kouklakis, G.; Tzarou, B.; Kokozidis, G.; Mandraveli, E.; Kosmidou, E.; Bezazi, E.

Book ID: 123290775
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 82 KB
Volume: 13
Category: Article
ISSN: 0168-8278
DOI: 10.1016/0168-8278(91)91516-J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant alpha-interferon treatment o

Recombinant alpha-interferon treatment of chronic hepatitis B in childhood: A controlled study

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A controlled study of lymphoblastoid int

A controlled study of lymphoblastoid interferon in chronic non-A, non-B hepatitis

✍ Sathinarain, M.; Harley, C.; Momoniat, E. 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 78 KB

A controled study of recombinant interfe

A controled study of recombinant interferon alpha treatment in chronic non-A, non-B hepatitis

✍ Kempny, Aleksander; Diller, Gerhard-Paul; Orwat, Stefan; Kaleschke, Gerrit; Kerc 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Randomised controlled trial of alfa inte

Randomised controlled trial of alfa interferon in chronic active hepatitis non A non B

✍ Marcellin, P.; Boyer, N.; Giostra, E.; Degos, F.; Coppere, H.; Cales, P.; Couzlg 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Comparative study of three doses of inte

Comparative study of three doses of interferon-α2a in chronic active hepatitis B

✍ H. C. Thomas; A. S. F. Lok; V. Carreño; G. Farrell; H. Tanno; V. Perez; G. M. Du 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 700 KB

Double-blind, randomized controlled tria

Double-blind, randomized controlled trial of interleukin-2 treatment of chronic hepatitis B

✍ Artillo, Santiago; Pastore, Giuseppe; Alberti, Alfredo; Milella, Michelle; Santa 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 1 views

Pilot studies have demonstrated that recombinant interleukin 2 (rIL-2) has an indirect antiviral activity against hepatitis B virus, but the minimal dose of rIL-2 for induction of this effect was not defined. The aim of the study was to ascertain the most efficient dose of rIL-2 for induction of the